Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 98,000 shares at $116.15 ($11.3M) on 2023-01-25, disclosed to the SEC on 2023-01-27.
Open-market sale of $11.3M BMRN by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.65 | 44,825 | $5.2M | 45.7% |
| 2 | $115.65 | 44,825 | $5.2M | 45.7% |
| 3 | $116.15 | 4,175 | $485K | 4.3% |
| 4 | $116.15 | 4,175 | $485K | 4.3% |
| Total | $115.69 avg | 98,000 | $11.3M | 100% |
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2022-11-04 | $258K | — | Filing → |